Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $44 | $78 | $102 | $39 |
| Short-Term Investments | $121 | $17 | $20 | $46 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $1 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $6 | $5 | $1 |
| Total Curr. Assets | $175 | $101 | $127 | $86 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $60 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $32 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $62 | $35 | $2 | $0 |
| Other Assets | $0 | $0 | $0 | $1 |
| Total Assets | $237 | $136 | $129 | -$75 |
| Liabilities | – | – | – | – |
| Payables | $7 | $4 | $8 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $18 | $6 | $0 | $0 |
| Other Curr. Liab. | $66 | $14 | $9 | $2 |
| Total Curr. Liab. | $90 | $23 | $17 | $4 |
| LT Debt | $24 | $1 | $1 | $0 |
| Deferred Rev, NC | $1 | $2 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $25 | $2 | $1 | $0 |
| Other Liabilities | $0 | $0 | $289 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $115 | $25 | $306 | $4 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $86 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$406 | -$292 | -$178 | -$79 |
| AOCI | -$1 | -$0 | -$0 | -$86 |
| Other Equity | $528 | $0 | $0 | $86 |
| Total Equity | $122 | -$292 | -$178 | -$79 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $237 | -$267 | $129 | -$75 |
| Net Debt | -$20 | -$78 | -$102 | -$39 |